The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors

This study highlights the importance of several factors involved in the formation of capillary-like structure formation (CLS) using Human Umbilical Vein Endothelial Cells (HUVEC) and Bovine Retinal Endothelial Cells (BREC) cultured on fibrin gels. The fibrin concentration inducing (CLS) was 0.5 mg/ml for HUVEC and 8 mg/ml for BREC. The high fibrin concentration required for the latter cells appeared necessary to counterbalance the extensive fibrinolysis of the gel by the BREC. Fibrin degradation products measured in the culture media showed that fibrin degradation was mandatory but not sufficient for CLS formation. Fibrin degradation acted in concert with the mechanical, concentration dependent properties of the gels to induce CLS. For example, HUVEC did not form CLS on a rigid fibrin of 8 mg/ml in spite of fibrinolysis. As cell reorganisation occurred, the fibrin was disrupted (HUVEC) or pleated (BREC) giving indirect proof of the development of mechanical forces. During CLS formation, an increasing amount of latent TGFβ1 was measured in the medium (1000–1700 pg/ml). The active form of TGFβ1 was not, however, detected and the addition of anti-TGF-β1 antibody to the medium did not influence the formation of the CLS network. Yet, added activated TGF-β1 led to the formation of less organised structures, that were completely abolished by the concomitant addition of the same anti-TGF-β1 antibody. Thus, it is likely that TGF-β1 secreted by the endothelial cells remained in its latent form. In conclusion, a balance between the mechanical properties of fibrin and the fibrinolytic activity of each cell type may regulate CLS formation in our models. We think that the high fibrinolitic activity of the BREC may represent a defense mechanism to protect the retina against thrombosis-induced damage in vivo.

[1]  J. Ferry Structure and Rheology of Fibrin Networks , 1988 .

[2]  H. Moses,et al.  Mechanism of activation of latent recombinant transforming growth factor beta 1 by plasmin , 1990, The Journal of cell biology.

[3]  H. Moses,et al.  Mechanism of Activation of Latent Recombinant Transforming Growth Factor by Plasmin , 2002 .

[4]  B. Ballermann,et al.  Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-β Receptors (*) , 1995, The Journal of Biological Chemistry.

[5]  K. Preissner,et al.  The urokinase receptor is a major vitronectin-binding protein on endothelial cells. , 1996, Experimental cell research.

[6]  J J Fredberg,et al.  Urokinase receptor mediates mechanical force transfer across the cell surface. , 1995, The American journal of physiology.

[7]  K. Weber,et al.  Immunofluorescence and immunocytochemical procedures with affinity purified antibodies: tubulin-containing structures. , 1982, Methods in cell biology.

[8]  L. Orci,et al.  Plasminogen activator inhibitor-1 is induced in microvascular endothelial cells by a chondrocyte-derived transforming growth factor-beta. , 1991, Biochemical and biophysical research communications.

[9]  P. Tracqui,et al.  In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to αvβ3 integrin localization , 1997, In Vitro Cellular & Developmental Biology - Animal.

[10]  R. Nicosia,et al.  Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[11]  L. Orci,et al.  Basic fibroblast growth factor induces angiogenesis in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Belin,et al.  The plasminogen activator/plasmin system. , 1991, The Journal of clinical investigation.

[13]  O. Kocher,et al.  Transforming growth factor beta1 modulates extracellular matrix organization and cell‐cell junctional complex formation during in vitro angiogenesis , 1990, Journal of cellular physiology.

[14]  R. A. Kekwick,et al.  The purification of human fibrinogen. , 1955, The Biochemical journal.

[15]  D E Ingber,et al.  Cell shape, cytoskeletal mechanics, and cell cycle control in angiogenesis. , 1995, Journal of biomechanics.

[16]  Judah Folkman,et al.  Angiogenesis in vitro , 1980, Nature.

[17]  P. Tracqui,et al.  Modelling Biological Gel Contraction by Cells: Mechanocellular Formulation and Cell Traction Force Quantification , 1997, Acta biotheoretica.

[18]  P. Yurchenco,et al.  Modulation of angiogenesis in vitro by laminin-entactin complex. , 1994, Developmental biology.

[19]  L. Orci,et al.  Biphasic Effect of Transforming Growth Factor-β1 on in Vitro Angiogenesis , 1993 .

[20]  H. Izumi,et al.  Inhibition of tubular morphogenesis in human microvascular endothelial cells by co-culture with chondrocytes and involvement of transforming growth factor beta: a model for avascularity in human cartilage. , 1994, Biochimica et biophysica acta.

[21]  A. Vaheri,et al.  Active transforming growth factor‐β in human melanoma cell lines: No evidence for plasmin‐related activation of latent TGF‐β , 1996 .

[22]  M. Lagarde,et al.  Docosahexaenoic Acid Is a Major n‐3 Polyunsaturated Fatty Acid in Bovine Retinal Microvessels , 1996, Journal of neurochemistry.

[23]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[24]  P. Brooks Cell adhesion molecules in angiogenesis , 1996, Cancer and Metastasis Reviews.

[25]  Donald E. Ingber,et al.  How does extracellular matrix control capillary morphogenesis? , 1989, Cell.

[26]  P. D’Amore,et al.  Endothelial cell regulation by transforming growth factor‐beta , 1991, Journal of cellular biochemistry.

[27]  J. Madri,et al.  Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix , 1988, The Journal of cell biology.

[28]  Richard A.F. Clark,et al.  The Molecular and Cellular Biology of Wound Repair , 2012, Springer US.

[29]  J Martinez,et al.  Fibrin II induces endothelial cell capillary tube formation , 1995, The Journal of cell biology.

[30]  E. Engvall,et al.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen , 1977, International journal of cancer.

[31]  L. Orci,et al.  Angiogenesis in Vitro: Cytokine Interactions and Balanced Extracellular Proteolysis , 1994 .

[32]  R. Friesel,et al.  Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  J. D. Salvo,et al.  Human Retinal Vascular Cells Differ from Umbilical Cells in Synthetic Functions and Their Response to Glucose , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  L. Orci,et al.  Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro , 1990, The Journal of cell biology.

[35]  W. Thompson,et al.  Plasmin, fibrin degradation and angiogenesis , 1996, Nature Medicine.

[36]  H. Schnaper,et al.  Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways , 1995, Journal of cellular physiology.

[37]  G. Davis,et al.  Regulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. , 1995, Experimental cell research.

[38]  E. Sage,et al.  Between molecules and morphology. Extracellular matrix and creation of vascular form. , 1995, The American journal of pathology.

[39]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[40]  Jaffe Ea,et al.  Culture of human endothelial cells. , 1980, Transplantation proceedings.

[41]  S. Mandriota,et al.  Transforming Growth Factor 1 Down-regulates Vascular Endothelial Growth Factor Receptor 2/flk-1 Expression in Vascular Endothelial Cells (*) , 1996, The Journal of Biological Chemistry.

[42]  C. Taylor,et al.  Improved mountant for immunofluorescence preparations. , 1974, Journal of clinical pathology.

[43]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[44]  V. Ellis,et al.  Mechanisms of plasminogen activation , 1994, Journal of internal medicine.

[45]  D. Cheresh Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[47]  D. Ingber,et al.  Integrins as mechanochemical transducers. , 1991, Current opinion in cell biology.

[48]  M. Sporn,et al.  Transforming growth factor-beta: recent progress and new challenges , 1992, The Journal of cell biology.

[49]  V. V. van Hinsbergh,et al.  Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity , 1996, The Journal of cell biology.

[50]  V. Bautch,et al.  Perturbations in the fibrinolytic pathway abolish cyst formation but not capillary-like organization of cultured murine endothelial cells. , 1994, Blood.

[51]  A. Vaheri,et al.  Distribution and lateral mobility of the urokinase-receptor complex at the cell surface. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[52]  L. Orci,et al.  Angiogenesis: a paradigm for balanced extracellular proteolysis during cell migration and morphogenesis. , 1996, Enzyme & protein.

[53]  T. Edgington,et al.  Human Platelets Possess an Inducible and Saturable Receptor Specific for Fibrinogen , 1979, Thrombosis and Haemostasis.